E
Eliane Gluckman
Researcher at University of Paris
Publications - 694
Citations - 48573
Eliane Gluckman is an academic researcher from University of Paris. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 112, co-authored 679 publications receiving 46415 citations. Previous affiliations of Eliane Gluckman include Medical College of Wisconsin & Leiden University.
Papers
More filters
Journal ArticleDOI
Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia
Franco Locatelli,Vanderson Rocha,Claude Chastang,William Arcese,Gérard Michel,Manoel Abecasis,Chiara Messina,Juan Ortega,Isabel Badell-Serra,Emanuel Plouvier,Gerard Souillet,Jean Pierre Jouet,Ricardo Pasquini,Euripedes Ferreira,Federico Garnier,Eliane Gluckman +15 more
TL;DR: Analysis of factors influencing the outcome of 102 children with acute leukemia given a cord blood transplantation (CBT) and reported to the Eurocord Registry confirms that allogeneic CBT from either a related or an unrelated donor is a feasible procedure able to cure a significant proportion of children with acutely leukemia.
Journal ArticleDOI
One million haemopoietic stem-cell transplants: a retrospective observational study
Alois Gratwohl,Marcelo C. Pasquini,Mahmoud Aljurf,Yoshiko Atsuta,Helen Baldomero,Lydia Foeken,Michael Gratwohl,Luis Fernando Bouzas,Dennis L. Confer,Karl Frauendorfer,Eliane Gluckman,Hildegard Greinix,Mary M. Horowitz,Minako Iida,Jeffrey H. Lipton,Alejandro Madrigal,Mohamad Mohty,Luc Noel,Nicolas Novitzky,José R. Nuñez,Machteld Oudshoorn,Jakob Passweg,Jon J. van Rood,Jeff Szer,Karl G. Blume,Frederic R Appelbaum,Yoshihisa Kodera,Dietger Niederwieser +27 more
TL;DR: The findings show achievements and high unmet needs and give guidance for decisions to grant access for patients, to provide a donor infrastructure, and to limit overuse by defining risk and region adapted indications for HSCT as an efficient and cost-effective approach for life-threatening, potentially curable diseases.
Journal ArticleDOI
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
Eliane Gluckman,Barbara Cappelli,Françoise Bernaudin,Myriam Labopin,Fernanda Volt,Jeanette Carreras,Belinda Pinto Simões,Alina Ferster,Sophie Dupont,Josu de la Fuente,Jean-Hugues Dalle,Marco Zecca,Mark C. Walters,Lakshmanan Krishnamurti,Monica Bhatia,Kathryn S. Leung,Gregory A. Yanik,Joanne Kurtzberg,Nathalie Dhedin,Mathieu Kuentz,Gérard Michel,Jane F. Apperley,Patrick Lutz,Bénédicte Neven,Yves Bertrand,J.P. Vannier,Mouhab Ayas,Marina Cavazzana,Marina Cavazzana,Marina Cavazzana,Susanne Matthes-Martin,Vanderson Rocha,Vanderson Rocha,Vanderson Rocha,Hanadi Elayoubi,Chantal Kenzey,Peter Bader,Franco Locatelli,Annalisa Ruggeri,Mary Eapen +39 more
TL;DR: The excellent outcome of a cohort transplanted over the course of 3 decades confirms the role of HLA-identical sibling transplantation for children and adults with SCD.
Journal ArticleDOI
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.
Richard E. Champlin,Mary M. Horowitz,D. W. van Bekkum,Bruce M. Camitta,GE Elfenbein,Robert Peter Gale,Eliane Gluckman,R.A. Good,A. A. Rimm,C. Rozman +9 more
TL;DR: Graft failure was analyzed in 625 patients receiving allogeneic bone marrow transplants from HLA-identical sibling donors as treatment for severe aplastic anemia and posttransplant treatment with cyclosporine and avoidance of pretransplant blood transfusions were associated with improved survival.
Journal ArticleDOI
Current status of umbilical cord blood hematopoietic stem cell transplantation
TL;DR: This large registry study confirms the potential benefit of using umbilical cord blood hematopoietic stem cells for allogeneic transplants and shows that survival with umbilicals cord blood transplants was comparable to that with related or unrelated bone marrow transplants.